| Politician | Action | Description | Traded |
|---|---|---|---|
| Buy | Novo Nordisk A/S Common Stoc | Mar 30, 2026 | |
| Sell | Novo Nordisk A/S Common Stoc | Oct 31, 2025 | |
| Sell | Novo Nordisk A/S Common Stoc | Oct 30, 2025 | |
| Sell | Novo Nordisk A/S Common Stoc | Oct 15, 2025 | |
| Sell | Novo Nordisk A/S Common Stoc | Sep 11, 2025 | |
| Sell | Novo Nordisk A/S Common Stoc | Aug 28, 2025 | |
| Sell | Novo Nordisk A/S Common Stoc | Aug 19, 2025 | |
| Sell | Novo Nordisk A/S Common Stoc | Aug 4, 2025 | |
| Sell | Novo Nordisk A/S Common Stoc | Aug 4, 2025 | |
| Sell | Novo Nordisk A/S Common Stoc | Aug 4, 2025 |
This page tracks congressional stock trading activity in Novo Nordisk A/S (NVO) in the Healthcare sector. Disclosed Capitol has indexed 61 disclosed congressional trades involving NVO. Every trade is sourced from official STOCK Act financial disclosure filings — the same primary records the Senate and House are required to publish. The full trade list with politician names, transaction types, amount ranges, and disclosure dates is below, alongside cross-references to any related lobbying activity, federal contracts, and committee assignments.
As of July 2026 — Disclosed Capitol has tracked 61 disclosed congressional trades in Novo Nordisk A/S (NVO) — 36:19 sell-heavy ratio — led by Michael McCaul (R).
| Date | Politician | Party | Action | Amount |
|---|---|---|---|---|
| Mar 30, 2026 | Alan Armstrong | R | Buy | $15,001 - $50,000 |
| Oct 31, 2025 | Lisa McClain | R | Sale | $1,001 - $15,000 |
| Oct 30, 2025 | Lisa McClain | R | Sale | $1,001 - $15,000 |
| Oct 15, 2025 | Marjorie Taylor Greene | R | Sale | $1,001 - $15,000 |
| Sep 11, 2025 | Lisa McClain | R | Sale | $1,001 - $15,000 |
| Aug 28, 2025 | Marjorie Taylor Greene | R | Sale | $1,001 - $15,000 |
| Aug 19, 2025 | Marjorie Taylor Greene | R | Sale | $15,001 - $50,000 |
| Aug 4, 2025 | C. Scott Franklin | R | Sale | $15,001 - $50,000 |
| Aug 4, 2025 | C. Scott Franklin | R | Sale | $1,001 - $15,000 |
| Aug 4, 2025 | Lisa McClain | R | Sale | $1,001 - $15,000 |
Across the 61 disclosed congressional trades in Novo Nordisk A/S (NVO), members of Congress have reported 19 buys and 36 sells. The average 30-day alpha vs. the S&P 500 is 1.11%.